Canadian preference and trends survey results for anti-VEGF treatment of macular edema.
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- June 2016
has subject area
- 1113 Opthalmology and Optometry (FoR)
- Angiogenesis Inhibitors (MeSH)
- Bevacizumab (MeSH)
- Canada (MeSH)
- Diabetic Retinopathy (MeSH)
- Drug Utilization (MeSH)
- Health Care Surveys (MeSH)
- Humans (MeSH)
- Macular Edema (MeSH)
- Ophthalmology & Optometry (Science Metrix)
- Practice Patterns, Physicians' (MeSH)
- Ranibizumab (MeSH)
- Receptors, Vascular Endothelial Growth Factor (MeSH)
- Recombinant Fusion Proteins (MeSH)
- Retinal Vein Occlusion (MeSH)
- Surveys and Questionnaires (MeSH)
- Vascular Endothelial Growth Factor A (MeSH)
- Wet Macular Degeneration (MeSH)